{"id":21221,"date":"2020-09-14T08:51:17","date_gmt":"2020-09-14T06:51:17","guid":{"rendered":"https:\/\/embryotools.com\/?p=21221"},"modified":"2020-09-14T17:20:56","modified_gmt":"2020-09-14T15:20:56","slug":"our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities","status":"publish","type":"post","link":"https:\/\/embryotools.com\/zh\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","title":{"rendered":"Our R&#038;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities"},"content":{"rendered":"<p class=\"qtranxs-available-languages-message qtranxs-available-languages-message-zh\">\u5bf9\u4e0d\u8d77\uff0c\u6b64\u5185\u5bb9\u53ea\u9002\u7528\u4e8e<a href=\"https:\/\/embryotools.com\/en\/wp-json\/wp\/v2\/posts\/21221\" class=\"qtranxs-available-language-link qtranxs-available-language-link-en\" title=\"English\">English<\/a>\u548c<a href=\"https:\/\/embryotools.com\/es\/wp-json\/wp\/v2\/posts\/21221\" class=\"qtranxs-available-language-link qtranxs-available-language-link-es\" title=\"Espa\u00f1ol\">Espa\u00f1ol<\/a>\u3002 For the sake of viewer convenience, the content is shown below in this site default language. You may click one of the links to switch the site language to another available language.<\/p><p>The Embryotools R&amp;D centre has received support from CDTI (Center for technological and industrial development) to carry out another innovative project with the aim to study new strategies to prevent or reduce the prevalence of chromosomal abnormalities at the early stages of the embryo development.<\/p>\n<p><a href=\"https:\/\/embryotools.com\/wp-content\/uploads\/2020\/09\/F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612.pdf\">F15c_Diploma_2377_002_20-200907-CER-RD_001-B66034612<\/a><\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>\u5bf9\u4e0d\u8d77\uff0c\u6b64\u5185\u5bb9\u53ea\u9002\u7528\u4e8eEnglish\u548cEspa\u00f1ol\u3002 For the sake of viewer conv&hellip;<\/p>\n","protected":false},"author":70,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"image","meta":{"footnotes":""},"categories":[13,173],"tags":[],"class_list":["post-21221","post","type-post","status-publish","format-image","hentry","category-about-us","category-in-the-news","post_format-post-format-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Our R&amp;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Our R&amp;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools\" \/>\n<meta name=\"twitter:description\" content=\"\u5bf9\u4e0d\u8d77\uff0c\u6b64\u5185\u5bb9\u53ea\u9002\u7528\u4e8eEnglish\u548cEspa\u00f1ol\u3002 For the sake of viewer conv&hellip;\" \/>\n<meta name=\"twitter:creator\" content=\"@embryotools\" \/>\n<meta name=\"twitter:site\" content=\"@embryotools\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paco Gibert\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"},\"author\":{\"name\":\"Paco Gibert\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/person\\\/386a367a590f99476a8702285aeaf403\"},\"headline\":\"Our R&#038;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities\",\"datePublished\":\"2020-09-14T06:51:17+00:00\",\"dateModified\":\"2020-09-14T15:20:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"},\"wordCount\":146,\"publisher\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\"},\"articleSection\":[\"About us\",\"News\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\",\"url\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\",\"name\":\"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#website\"},\"datePublished\":\"2020-09-14T06:51:17+00:00\",\"dateModified\":\"2020-09-14T15:20:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/embryotools.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our R&#038;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#website\",\"url\":\"https:\\\/\\\/embryotools.com\\\/\",\"name\":\"Embryotools\",\"description\":\"for better results\",\"publisher\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/embryotools.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#organization\",\"name\":\"Embryotools\",\"url\":\"https:\\\/\\\/embryotools.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/embryotools.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/embryotools_logo_trans_500-2.png\",\"contentUrl\":\"https:\\\/\\\/embryotools.com\\\/wp-content\\\/uploads\\\/2017\\\/01\\\/embryotools_logo_trans_500-2.png\",\"width\":250,\"height\":59,\"caption\":\"Embryotools\"},\"image\":{\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/embryotools\",\"https:\\\/\\\/x.com\\\/embryotools\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/embryotools\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/embryotools.com\\\/#\\\/schema\\\/person\\\/386a367a590f99476a8702285aeaf403\",\"name\":\"Paco Gibert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g\",\"caption\":\"Paco Gibert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","twitter_card":"summary_large_image","twitter_title":"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools","twitter_description":"\u5bf9\u4e0d\u8d77\uff0c\u6b64\u5185\u5bb9\u53ea\u9002\u7528\u4e8eEnglish\u548cEspa\u00f1ol\u3002 For the sake of viewer conv&hellip;","twitter_creator":"@embryotools","twitter_site":"@embryotools","twitter_misc":{"\u4f5c\u8005":"Paco Gibert","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"1 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#article","isPartOf":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"},"author":{"name":"Paco Gibert","@id":"https:\/\/embryotools.com\/#\/schema\/person\/386a367a590f99476a8702285aeaf403"},"headline":"Our R&#038;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities","datePublished":"2020-09-14T06:51:17+00:00","dateModified":"2020-09-14T15:20:56+00:00","mainEntityOfPage":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"},"wordCount":146,"publisher":{"@id":"https:\/\/embryotools.com\/#organization"},"articleSection":["About us","News"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","url":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/","name":"Our R&D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities - Embryotools","isPartOf":{"@id":"https:\/\/embryotools.com\/#website"},"datePublished":"2020-09-14T06:51:17+00:00","dateModified":"2020-09-14T15:20:56+00:00","breadcrumb":{"@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/embryotools.com\/our-rd-centre-receive-support-from-cdti-to-study-new-strategies-to-prevent-prevalence-of-chromosomal-abnormalities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/embryotools.com\/"},{"@type":"ListItem","position":2,"name":"Our R&#038;D centre receives support from CDTI to study new strategies to prevent prevalence of chromosomal abnormalities"}]},{"@type":"WebSite","@id":"https:\/\/embryotools.com\/#website","url":"https:\/\/embryotools.com\/","name":"Embryotools","description":"for better results","publisher":{"@id":"https:\/\/embryotools.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/embryotools.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/embryotools.com\/#organization","name":"Embryotools","url":"https:\/\/embryotools.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/embryotools.com\/#\/schema\/logo\/image\/","url":"https:\/\/embryotools.com\/wp-content\/uploads\/2017\/01\/embryotools_logo_trans_500-2.png","contentUrl":"https:\/\/embryotools.com\/wp-content\/uploads\/2017\/01\/embryotools_logo_trans_500-2.png","width":250,"height":59,"caption":"Embryotools"},"image":{"@id":"https:\/\/embryotools.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embryotools","https:\/\/x.com\/embryotools","https:\/\/www.linkedin.com\/company\/embryotools"]},{"@type":"Person","@id":"https:\/\/embryotools.com\/#\/schema\/person\/386a367a590f99476a8702285aeaf403","name":"Paco Gibert","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/336d60b09be3aee81b14442f83edfb03b1ab90a6c9fa7328629cf3a812cd2610?s=96&d=mm&r=g","caption":"Paco Gibert"}}]}},"_links":{"self":[{"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/posts\/21221","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/users\/70"}],"replies":[{"embeddable":true,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/comments?post=21221"}],"version-history":[{"count":5,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/posts\/21221\/revisions"}],"predecessor-version":[{"id":22973,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/posts\/21221\/revisions\/22973"}],"wp:attachment":[{"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/media?parent=21221"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/categories?post=21221"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/embryotools.com\/zh\/wp-json\/wp\/v2\/tags?post=21221"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}